Sfoglia per Autore EANDI, Chiara Maria
Integrating network pharmacology: The next-generation approach in ocular drug discovery
2024-01-01 Lazzara, Francesca; Conti, Federica; Giuffrida, Erika; Eandi, Chiara Maria; Drago, Filippo; Platania, Chiara Bianca Maria; Bucolo, Claudio
Drug-Repurposing Strategy for Dimethyl Fumarate
2023-01-01 Giunta, Salvatore; D'Amico, Agata Grazia; Maugeri, Grazia; Bucolo, Claudio; Romano, Giovanni Luca; Rossi, Settimio; Eandi, Chiara M; Pricoco, Elisabetta; D'Agata, Velia
Influence of macular pigment on the sensitivity to discomfort glare from daylight
2023-01-01 Jain, Sneha; Wienold, Jan; Eandi, Chiara; Gisselbaek, Sara; Kawasaki, Aki; Andersen, Marilyne
Brolucizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Ophthalmology and Diabetology Treatment Aspects
2023-01-01 Garweg, Justus G; Blum, Claudine A; Copt, René-Pierre; Eandi, Chiara M; Hatz, Katja; Prünte, Christian F; Seelig, Eleonora; Somfai, Gábor M
Kinetic Perimetry on Virtual Reality Headset
2023-01-01 Terracciano, Rossana; Mascolo, Alice; Venturo, Laura; Guidi, Federica; Vaira, Mariangela; Eandi, Chiara M; Demarchi, Danilo
Central Retinal Vein Occlusion after COVID-19 Infection
2023-01-01 Nguyen, Ngoc-Chau Isabelle; Eandi, Chiara; Guex-Crosier, Yan
Early Residual Fluid-Free Status and Long-Term BCVA Outcomes: A Treatment Agnostic, Post Hoc Analysis of Pooled HAWK and HARRIER Data
2022-01-01 Jhaveri, Chirag; Wykoff, Charles C; Khanani, Arshad M; Eandi, Chiara M; Chang, Andrew; B, Guruprasad; Gedif, Kinfemichael A; Singer, Michael
Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial.
2022-01-01 Garweg JG, Štefanickova J, Hoyng C, Niesen T, Schmelter T, Leal S, Sivaprasad S; Eandi CM; VIOLET Investigators.
Bilateral acute macular neuroretinopathy following COVID-19 infection
2022-01-01 Giacuzzo, Clarice; Eandi, Chiara M; Kawasaki, Aki
Editorial: Ocular Pharmacology: Recent Breakthroughs and Unmet Needs
2022-01-01 Bucolo C.; Toro M.D.; Eandi C.M.
Early OCTA Changes of Type 3 Macular Neovascularization Following Brolucizumab Intravitreal Injections
2022-01-01 Gigon, Anthony; Vadalà, Maria; Bonfiglio, Vincenza M E; Reibaldi, Michele; Eandi, Chiara M
Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic care
2022-01-01 Sirks M.J.; van Dijk E.H.C.; Rosenberg N.; Hollak C.E.M.; Aslanis S.; Cheung C.M.G.; Chowers I.; Eandi C.M.; Freund K.B.; Holz F.G.; Kaiser P.K.; Lotery A.J.; Ohno-Matsui K.; Querques G.; Subhi Y.; Tadayoni R.; Wykoff C.C.; Zur D.; Diederen R.M.H.; Boon C.J.F.; Schlingemann R.O.
Inverted internal limiting membrane flap technique for macular hole coexistent with rhegmatogenous retinal detachment
2022-01-01 Stappler T.; Montesel A.; Konstantinidis L.; Wolfensberger T.J.; Eandi C.M.
Pathogenesis of Vascular Retinal Manifestations in COVID-19 Patients: A Review
2022-01-01 D'Alessandro E, Kawasaki A, Eandi CM.
TREATMENT DEFERRAL DURING COVID-19 LOCKDOWN: Functional and Anatomical Impact on Patients With Neovascular Age-Related Macular Degeneration
2022-01-01 Montesel A.; Gigon A.; Giacuzzo C.; Mantel I.; Eandi C.M.
Fluid dynamics between injections in incomplete anti-VEGF responders within neovascular age-related macular degeneration: a prospective observational study.
2022-01-01 Gigon A, Iskandar A, Eandi CM, Mantel I
WARE: Wet AMD Risk-Evaluation Tool as a Clinical Decision-Support System Integrating Genetic and Non-Genetic Factors.
2022-01-01 Fabrizio C, Termine A, Caputo V, Megalizzi D, Zampatti S, Falsini B, Cusumano A, Eandi CM, Ricci F, Giardina E, Strafella C, Cascella R.
Effects of circadian rhythm disruption on retinal physiopathology: Considerations from a consensus of experts.
2022-01-01 Parravano M, Eandi CM, Figus M, Lupidi M, Menchini F, Nicolo M, Parisi V, Toto L, Viola F, Vujosevic S, Querques G.
Short-Term Efficacy and Safety Outcomes of Brolucizumab in the Real-Life Clinical Practice
2021-01-01 Montesel A.; Bucolo C.; Sallo F.B.; Eandi C.M.
A New Method for Visualizing Drusen and Their Progression in Flood-Illumination Adaptive Optics Ophthalmoscopy
2021-01-01 Rossi E.A.; Norberg N.; Eandi C.; Chaumette C.; Kapoor S.; Le L.; Snyder V.C.; Martel J.N.; Gautier J.; Gocho K.; Dansingani K.K.; Chhablani J.; Arleo A.; Mrejen S.; Sahel J.-A.; Grieve K.; Paques M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Integrating network pharmacology: The next-generation approach in ocular drug discovery | 2024 | Lazzara, Francesca; Conti, Federica; Giuffrida, Erika; Eandi, Chiara Maria; Drago, Filippo; Platania, Chiara Bianca Maria; Bucolo, Claudio | |
| Drug-Repurposing Strategy for Dimethyl Fumarate | 2023 | Giunta, Salvatore; D'Amico, Agata Grazia; Maugeri, Grazia; Bucolo, Claudio; Romano, Giovanni Luca; Rossi, Settimio; Eandi, Chiara M; Pricoco, Elisabetta; D'Agata, Velia | |
| Influence of macular pigment on the sensitivity to discomfort glare from daylight | 2023 | Jain, Sneha; Wienold, Jan; Eandi, Chiara; Gisselbaek, Sara; Kawasaki, Aki; Andersen, Marilyne | |
| Brolucizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Ophthalmology and Diabetology Treatment Aspects | 2023 | Garweg, Justus G; Blum, Claudine A; Copt, René-Pierre; Eandi, Chiara M; Hatz, Katja; Prünte, Christian F; Seelig, Eleonora; Somfai, Gábor M | |
| Kinetic Perimetry on Virtual Reality Headset | 2023 | Terracciano, Rossana; Mascolo, Alice; Venturo, Laura; Guidi, Federica; Vaira, Mariangela; Eandi, Chiara M; Demarchi, Danilo | |
| Central Retinal Vein Occlusion after COVID-19 Infection | 2023 | Nguyen, Ngoc-Chau Isabelle; Eandi, Chiara; Guex-Crosier, Yan | |
| Early Residual Fluid-Free Status and Long-Term BCVA Outcomes: A Treatment Agnostic, Post Hoc Analysis of Pooled HAWK and HARRIER Data | 2022 | Jhaveri, Chirag; Wykoff, Charles C; Khanani, Arshad M; Eandi, Chiara M; Chang, Andrew; B, Guruprasad; Gedif, Kinfemichael A; Singer, Michael | |
| Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial. | 2022 | Garweg JG, Štefanickova J, Hoyng C, Niesen T, Schmelter T, Leal S, Sivaprasad S; Eandi CM; VIOLET Investigators. | |
| Bilateral acute macular neuroretinopathy following COVID-19 infection | 2022 | Giacuzzo, Clarice; Eandi, Chiara M; Kawasaki, Aki | |
| Editorial: Ocular Pharmacology: Recent Breakthroughs and Unmet Needs | 2022 | Bucolo C.; Toro M.D.; Eandi C.M. | |
| Early OCTA Changes of Type 3 Macular Neovascularization Following Brolucizumab Intravitreal Injections | 2022 | Gigon, Anthony; Vadalà, Maria; Bonfiglio, Vincenza M E; Reibaldi, Michele; Eandi, Chiara M | |
| Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic care | 2022 | Sirks M.J.; van Dijk E.H.C.; Rosenberg N.; Hollak C.E.M.; Aslanis S.; Cheung C.M.G.; Chowers I.; Eandi C.M.; Freund K.B.; Holz F.G.; Kaiser P.K.; Lotery A.J.; Ohno-Matsui K.; Querques G.; Subhi Y.; Tadayoni R.; Wykoff C.C.; Zur D.; Diederen R.M.H.; Boon C.J.F.; Schlingemann R.O. | |
| Inverted internal limiting membrane flap technique for macular hole coexistent with rhegmatogenous retinal detachment | 2022 | Stappler T.; Montesel A.; Konstantinidis L.; Wolfensberger T.J.; Eandi C.M. | |
| Pathogenesis of Vascular Retinal Manifestations in COVID-19 Patients: A Review | 2022 | D'Alessandro E, Kawasaki A, Eandi CM. | |
| TREATMENT DEFERRAL DURING COVID-19 LOCKDOWN: Functional and Anatomical Impact on Patients With Neovascular Age-Related Macular Degeneration | 2022 | Montesel A.; Gigon A.; Giacuzzo C.; Mantel I.; Eandi C.M. | |
| Fluid dynamics between injections in incomplete anti-VEGF responders within neovascular age-related macular degeneration: a prospective observational study. | 2022 | Gigon A, Iskandar A, Eandi CM, Mantel I | |
| WARE: Wet AMD Risk-Evaluation Tool as a Clinical Decision-Support System Integrating Genetic and Non-Genetic Factors. | 2022 | Fabrizio C, Termine A, Caputo V, Megalizzi D, Zampatti S, Falsini B, Cusumano A, Eandi CM, Ricci F, Giardina E, Strafella C, Cascella R. | |
| Effects of circadian rhythm disruption on retinal physiopathology: Considerations from a consensus of experts. | 2022 | Parravano M, Eandi CM, Figus M, Lupidi M, Menchini F, Nicolo M, Parisi V, Toto L, Viola F, Vujosevic S, Querques G. | |
| Short-Term Efficacy and Safety Outcomes of Brolucizumab in the Real-Life Clinical Practice | 2021 | Montesel A.; Bucolo C.; Sallo F.B.; Eandi C.M. | |
| A New Method for Visualizing Drusen and Their Progression in Flood-Illumination Adaptive Optics Ophthalmoscopy | 2021 | Rossi E.A.; Norberg N.; Eandi C.; Chaumette C.; Kapoor S.; Le L.; Snyder V.C.; Martel J.N.; Gautier J.; Gocho K.; Dansingani K.K.; Chhablani J.; Arleo A.; Mrejen S.; Sahel J.-A.; Grieve K.; Paques M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile